Skip to main content
. 2002 Sep 4;87(6):681–686. doi: 10.1038/sj.bjc.6600494

Figure 4.

Figure 4

Inhibition of 3′-p-hydroxypaclitaxel formation by ketoconazole in colorectal cancer. The experiments were carried out in pooled microsomes from colorectal cancer. The percentage of activity is referred to the activity in the absence of inhibitor. Results are mean±s.d. of three independent experiments.